GEVOKIZUMAB
UNII QX3JU54GYQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Gevokizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QX3JU54GYQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1129435-60-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QX3JU54GYQ

CAS Registry Number

1129435-60-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GEVOKIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C97945

National Cancer Institute reference terminology for clinical and research data.

INN ID

9310

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-131

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gevokizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GEVOKIZUMAB

Common Names & Synonyms

GEVOKIZUMAB [INN]

GEVOKIZUMAB [USAN]

GEVOKIZUMAB [WHO-DD]

IMMUNOGLOBULIN G2, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN-MUS MUSCULUS XOMA 052 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS XOMA 052 .KAPPA.-CHAIN, DIMER